About 4 million American adults have the chronic condition. Treatment may include a combination of painkillers, cognitive ...

No serious side effects or discomfort observed Final safety and absorption data expected in March 2025 SARASOTA, FL, Feb. 11, ...

Disturbed sleep is a prominent feature of fibromyalgia symptomatology and has been proposed as one of the core symptoms that should be systematically assessed in clinical trials for the treatment ...

Dec. 22, 2023 — There does not appear to be any profound differences between so-called exposure-based CBT and traditional CBT in the treatment of fibromyalgia. Both forms of treatment produced a ...

SARASOTA, FL - Silo Pharma , Inc. (NASDAQ:SILO), a $6.91 million market cap biopharmaceutical company currently trading at $1.54 per share, has announced promising preliminary results from a study on ...

Fibromyalgia is a complex, chronic disorder characterized by widespread musculoskeletal pain, fatigue, sleep disturbances, ...

A small study confirms observations what users have observed: the medications reduce their cravings for alcohol.

The global hot trend is arriving in the south, at the clinic of Dr. Eitan Levitas, as part of the 360 approach he developed.

A new study of Australians living with chronic physical health conditions has found family members and doctors often dismiss ...

Silo Pharma (SILO) announced am update from an ongoing study evaluating the pharmacokinetics, safety and tolerability of its novel SP-26 ...

Anxieties about malingering or feigned illness are at least a thousand years old in the West”, argued public health ethicist ...